| Financial Year |
March 31 2023 |
| Monetary Funds |
733,768,279.82 |
| Held-for-trading Financial Assets |
369,411,030.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
489,162,796.24 |
| Advances to Suppliers |
75,481,338.05 |
| Other Receivables |
35,292,624.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,358,319.44 |
| Inventories |
324,115,427.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
357,278,531.54 |
| Other Current Assets |
26,189,529.11 |
| Total Current Assets |
2,412,795,202.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
12,200,801.40 |
| Long-term Equity Investment |
52,772,412.38 |
| Investment Properties |
-- |
| Fixed Assetes |
436,985,196.55 |
| Under-construction Projects |
106,661,903.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
99,136,569.19 |
| R&D expenses |
45,270,627.30 |
| Goodwill |
26,135,621.88 |
| Long-Term Deferred and Prepaid Expenses |
11,366,772.30 |
| Deferred Income Tax Assets |
31,315,764.51 |
| Other Non-Current Assets |
269,957,057.52 |
| Sub-Total of Non-Current Assets |
1,259,178,137.88 |
| Total Assets |
3,671,973,340.42 |
| Short-Term Loans |
545,658,277.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
112,563,060.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
43,036,144.19 |
| Taxes Payable |
16,997,924.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,854,679.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,555,818.43 |
| Other Current Liabilities |
6,336,692.21 |
| Sub-Total of Current Liabilities |
842,234,747.72 |
| Long-term Loans |
3,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
236,480.62 |
| Deferred Income Tax Liabilities |
18,769,724.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
50,022,859.56 |
| Total Liabilities |
892,257,607.28 |
| Paid-In Capital(Or Share Stock) |
507,153,517.00 |
| Capital Surplus |
317,203,230.44 |
| Surplus Reserve |
200,429,447.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,576,474,025.59 |
| Minority Stockholder's Interest |
176,526,314.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,603,189,418.94 |
| Owner's Equity（Stockholder's Equity） |
2,779,715,733.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,671,973,340.42 |
